BigPharma and morals don't even belong in the same sentence, however...
I have some sympathy for Lilly and the medical/clinical establishment as the whole GLP1 market is a shitshow and they have been trying to rein it in with stricter guidelines, regulations and inspections with very little success.
In the UK, use of prescribed medication has always been closely controlled by the NHS and prescribers. When the prices were set for the UK they were considerably lower than the rest of the world which has led to a scramble akin to a gold rush by pharmacies who have, apparently, in their rush to hit big money, broken professional guidelines right, left and centre in some cases (e.g. selling outside the UK, supplying more frequently than 4-weekly, inadequate checks for eligibility, procedures to prevent ordering from multiple companies not enforced, etc) while some users, with no clinical qualifications and, seemingly, very little intelligence have been spamming social media with "advice" on unapproved dosage schedules and using the drug outside of the terms of the product license as well as not eating and poor lifestyle advice. Even on MN we have seen posts about people sharing pens, buying from others, living overseas but buying here and all sorts of behaviours outside of the reasonable tweaks we might all make quietly for ourselves.
The whole thing is an unseemly debacle and Mounjaro is not being treated with the respect people normally have for prescribed medication.
In the USA the private medication market is controlled, largely, by insurance and high prices so it will be interesting to see if these changes rein it in at all where stricter guidance and inspection has not.
I am obviously sorry, though, for those people who have been using this sensibly and now find themselves priced out through no fault of their own.